Clinical Trial

Feasibility Assessment of the Wellumio 'Axana' 0.1T Portable MRI Device

Completed
View on ClinicalTrials.gov →
Summary
To assess the safety and feasibility of the Wellumio 'Axana' device in the hospital setting with healthy controls and patients.
Trial Details
NCT Number NCT07751328
Lead Sponsor Wellumio R&D Australia Pty Ltd
Conditions Stroke, Acute Stroke, Ischemic Stroke, Hemorrhagic Stroke
Enrollment 60 participants
Start Date 2024-07-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07